Monitoring Agency Report for the quarter ended 31st March, 2026
PAVNAIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Limited has submitted its monitoring agency report for Pavna Industries' preferential issue of equity shares and fully convertible warrants amounting to Rs. 210.70 crore. The report confirms no deviations from the stated objects of the issue. Of the total proceeds, Rs. 119.80 crore (57%) has been received so far, comprising the full equity share proceeds of Rs. 89.50 crore plus 25% of warrant proceeds. The balance Rs. 90.90 crore is to be received in tranches within 18 months from the January 2025 allotment date. The current market price of Rs. 21 per share (post-split) compares to a post-split equivalent conversion price of Rs. 50.50 per share, indicating the warrants are currently out of the money. Strategic acquisitions, one of the stated objects, have not yet been identified. Fund utilization stands at Rs. 119.80 crore with Rs. 0.34 crore remaining in the monitoring account.
This is a routine compliance filing confirming proper utilization of preferential issue proceeds. The gap between market price and conversion price suggests warrant holders may face dilution risk if the stock does not appreciate significantly. No material concerns flagged by the monitoring agency.